High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH)

Annals of Oncology

Volumn 22, Issue 12, 2011, Pages 2696-

  Kenz, S ^a   Haas, C S ^b   Werth, S C ^b   Bohnet, S ^b   Brabant, G ^a,b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEMECLOCYCLINE; SODIUM; TOLVAPTAN;

ADULT; AGED; BILE DUCT CARCINOMA; CANCER MORTALITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SENSITIVITY; DRUG WITHDRAWAL; ESOPHAGUS CARCINOMA; FEMALE; FLUID INTAKE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LETTER; LIPOSARCOMA; LONG TERM CARE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MYELOMA; PARANEOPLASTIC SYNDROME; PLASMA OSMOLALITY; PRIORITY JOURNAL; SODIUM URINE LEVEL; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT RESPONSE; URINE OSMOLALITY;

EID: 82355191824     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr431     Document Type: Letter

References (6)

1. Hansen O, Sorensen P, Hansen KH. The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period. Lung Cancer 2010; 68: 110-114.
2. Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 2010; 85: 838-854.
3. Schrier RW, Gross P, Gheorghiade M et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006; 355: 2099-2112.
4. Sterns RH, Silver S, Kleinschmidt-DeMasters BK, Roijani AM. Current perspectives in the management of hyponatremia: prevention of CPM. Expert Rev Neurother 2007; 7: 1791-1797.
5. Velez JC, Dopson SJ, Sanders DS et al. Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience. Nephrol Dial Transplant 2010; 25: 1524-1531.
6. Palm C, Wagner A, Gross P. [Hypo- and hypernatremia]. Dtsch Med Wochenschr 2011; 136: 29-33.